New Treatment Could Transform Lives of Millions with Asthma in Just Three Years
14 seconds ago
- UK scientists announce a breakthrough with Benralizumab for asthma.
- Benralizumab is 30% more effective than steroids for severe asthma.
- UK trials show a big drop in emergency visits with Benralizumab.
- The treatment may be used at home once fully approved.
- King's College London study involved 158 patients in trials.
- Current results show fewer failed treatments with Benralizumab.
- Approval expected in 2-3 years; global life-saving potential noted.